Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
JSPR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
JSPR
Jasper Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
JSPR
Jasper Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
JSPR, solid
AMGN, dashed
JSPR
Jasper Therapeutics, Inc.
Change
0.47
· pre 0.48
· delayed
Mkt cap
$13.5M
Revenue
—
Revenue
—
AMGN
Amgen Inc
Change
461.49
· pre 448.53
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
JSPR
Jasper Therapeutics, Inc.
vs
AMGN
Amgen Inc
0.47
pre 0.48
delayed
Price
461.49
pre 448.53
delayed
$13.5M
Mkt cap
$249.0B
—
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
JSPR
0.47
vs
AMGN
461.49
Pre-market
Nov 6 '26
delayed